What is AN2 Therapeutics, Inc. Common Stock's Market Cap?

AN2 Therapeutics, Inc. Common Stock's Market Cap is $216.2M, based on as-reported figures from SEC (XBRL) filings.

What is AN2 Therapeutics, Inc. Common Stock's Enterprise Value?

AN2 Therapeutics, Inc. Common Stock's Enterprise Value is $171.9M, based on as-reported figures from SEC (XBRL) filings.

What is AN2 Therapeutics, Inc. Common Stock's Net Income (TTM)?

AN2 Therapeutics, Inc. Common Stock's Net Income (TTM) is -$36.3M, based on as-reported figures from SEC (XBRL) filings.

What is AN2 Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

AN2 Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.96, based on as-reported figures from SEC (XBRL) filings.

What is AN2 Therapeutics, Inc. Common Stock's Net Debt?

AN2 Therapeutics, Inc. Common Stock's Net Debt is -$44.3M, based on as-reported figures from SEC (XBRL) filings.

AN2 Therapeutics, Inc. Common Stock (ANTX) Financial Statements

AN2 Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00QYLYBL3

XNAS · usd

5.73▼ 0.25 (-4.18%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close5.98

Day's Range5.61 – 6.13

52-Week Range1.00 – 7.19

Volume175.8K

Avg Volume226.7K

Share Statistics

Shares Outstanding

Employees21

ExchangeXNAS

Listed2022-03-25

Share count as of August 6, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about AN2 Therapeutics, Inc. Common Stock (ANTX)

What is AN2 Therapeutics, Inc. Common Stock's Market Cap?: AN2 Therapeutics, Inc. Common Stock's Market Cap is $216.2M, based on as-reported figures from SEC (XBRL) filings.
What is AN2 Therapeutics, Inc. Common Stock's Enterprise Value?: AN2 Therapeutics, Inc. Common Stock's Enterprise Value is $171.9M, based on as-reported figures from SEC (XBRL) filings.
What is AN2 Therapeutics, Inc. Common Stock's Net Income (TTM)?: AN2 Therapeutics, Inc. Common Stock's Net Income (TTM) is -$36.3M, based on as-reported figures from SEC (XBRL) filings.
What is AN2 Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: AN2 Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.96, based on as-reported figures from SEC (XBRL) filings.
What is AN2 Therapeutics, Inc. Common Stock's Net Debt?: AN2 Therapeutics, Inc. Common Stock's Net Debt is -$44.3M, based on as-reported figures from SEC (XBRL) filings.